PQQ OCT Glutathione Vitamin K2 Coenzyme Q10 Vegan Vitamin D3 Creatine monohydrate L-methylfolate DTF powder and Film Microencapsulated Vitamins
Dyestuff Nutrition Pharmaceutical DTF Powder and DTF Film
Nutrition news Dyestuff news Vitamins Knowledge L-Methylfolate Knowledge
Release time：2026-06-04 Click:
Home >News >Nutrition news
For ingredients sourcing managers in the dietary supplement industry, structural integrity is the primary hurdle of active folate delivery. Folic acid has historically filled this gap, yet its poor biological availability and bioconversion limits have driven the rapid rise of L‑methylfolate bulk powder, specifically L‑5‑Methyltetrahydrofolate Calcium (L‑5‑MTHF‑Ca). However, as quality control technicians can attest, L‑5‑MTHF‑Ca in raw powder form presents unique crystallographic and shelf‑stability hurdles during active formulation. This technical reference breaks down the critical molecular parameters that govern L‑5‑MTHF‑Ca powder behaviour and its performance across varying thermal and moisture stressors – and we’re here to help you navigate every step.
From an analytical chemistry perspective, L‑5‑MTHF‑Ca is the calcium salt of N‑[4‑[[(2‑amino‑3,4,7,8‑tetrahydro‑5‑methyl‑4‑oxo‑6‑pteridinyl)methyl]amino]benzoyl]‑L‑glutamic acid. The molecular formula of the pure compound is C20H23CaN7O6 with a molecular weight of 497.52 g/mol. The active bio‑functional moiety is the L‑isomeric form, also known as the 6S‑isomer, while the synthetic 6R‑isomer is biologically inactive. QC technicians must establish chiral verification via high‑performance liquid chromatography (HPLC) to ensure enantiomeric purity is no less than 99.0%, as minor racemic shifts significantly degrade metabolic efficacy. Raw crystalline powder demonstrates an intrinsic density of approximately 1.62 g/cm³, packing a fine particle size distribution where 90% of particles (D90) fall below 15 microns to guarantee processing consistency in high‑speed tablet presses. For formulators targeting pregnancy nutrition, active folate for prenatal supplements must meet these stringent stereochemical benchmarks to support maternal and fetal health safely.
Thermal gravimetric analysis (TGA) and differential scanning calorimetry (DSC) reveal that L‑5‑MTHF‑Ca lacks a traditional sharp melting point; instead, it undergoes a multi‑stage thermal degradation sequence. The initial phase is characterized by the loss of bound crystallization water, which begins at 85 °C and peaks near 120 °C, accounting for a steady 4.5% weight loss. Crucially, the dry, desolvated molecule remains thermally intact up to 180 °C. Above 215 °C, exothermic pyrolytic decomposition of the folate ring initiates, marked by a rapid loss of structural carbon. Quality control officers must treat 175 °C as the absolute upper boundary during formulation processing – especially in hot‑melt extrusion or pelletizing – to prevent thermal oxidation of the pteridine ring. When sourcing active folate raw material for dietary supplements, always request thermal stability profiles from your supplier; it makes all the difference in real‑world manufacturing.
To evaluate shelf longevity, our QC laboratory subjected standard raw amorphous L‑5‑MTHF‑Ca powder and highly crystallized variants to strict accelerated stability testing according to ICH guidelines. The empirical data over a 24‑month horizon yields clear, critical performance divergences.
Under standard storage conditions (25 °C, 60% RH), crystallized L‑5‑MTHF‑Ca powder maintains an active retention rate of 99.2% at 6 months, 98.4% at 12 months, and 97.12% at 24 months. In sharp contrast, amorphous powder under the same 25 °C parameters declines to 91.5% retention at 12 months and collapses to 81.3% by month 24, primarily driven by oxidative dimerization. Even synthetic L‑5‑MTHF Ca of high crystallinity outperforms amorphous forms consistently.
When environmental stress is accelerated to 40 °C and 75% RH (simulating extreme maritime cargo transit), the degradation pathways accelerate dramatically. The crystallized L‑5‑MTHF‑Ca powder experiences a manageable active loss, retaining 99.6% purity at 3 months,99.3% at 6 months. Concurrently, the amorphous raw material under the same 40 °C stress drops directly to 94.3% purity at 3 months and undergoes complete physical collapse into a brown, gummy residue with less than 42.0% active folate content at the 6‑month assay threshold.
Further, when raw powders are exposed to an extreme dry‑heat stress test at 60 °C for a rapid 30‑day trial, crystallized folate retains a highly robust 96.5% of its starting molecular configuration, whereas standard folic acid powder under identical conditions drops to 89.2% and amorphous MTHF‑Ca plummets to 61.0% active molecules. This clearly demonstrates that highly crystalline powder structures provide an internal steric shield against thermal molecular dislocation. In short, if you’re looking for a bioavailable folate ingredient, the crystalline form is your reliable partner.
To preserve these active molecular counts during large‑scale manufacturing, raw material storage must reject standard polyethylene liners in favour of triple‑laminated aluminium foil bags under continuous nitrogen purging. Warehouse moisture levels must be maintained strictly below 45% RH. Because the degradation index increases by a factor of 2.4 for every 10% rise in relative humidity above the 50% critical threshold, dehumidification of weight‑batching suites represents a critical control point (CCP) in oral dosage QC routing. Always remember: even the best L‑methylfolate bulk powder needs the right environment to shine – and we’re here to support you with expert guidance.
Leadingchem your trusted partner for premium L‑methylfolate (https://www.leadingchemical.com/gb2312/Lmethylfolate/) bulk powder and bioavailable folate ingredients. Contact us today for reliable, crystalline‑grade active folate solutions tailored to your formulation needs.
[1] PubChem Compound Database; CID: 135398685 (L-5-Methyltetrahydrofolate Calcium).
[2] European Food Safety Authority (EFSA) Journal; Scientific Opinion on the Safety and Efficacy of Folate Sources for Supplemental Use.
[3] National Center for Biotechnology Information (NCBI). “Stability Comparison of Crystalline vs Amorphous Folates under ICH Conditions.”
[4] World Health Organization (WHO) Technical Report Series – Folate stability in supplement manufacturing.
